Neudle.com: dopamine agonist

Differential
(Click to cross reference)

acrochordon

acromegaly

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

altered states of consciousness, driving with

anemia, iron deficiency

angiography, cerebral

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anxiety

aortic valve, lesion of

aphasia

aphasia, rehabilitation

apomorphine

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

arteriopathy

aspirin

ataxia, truncal

attention deficit disorder with hyperactivity

atypical

automobile accidents

autonomic dysfunction

behavioral disorder

benzodiazepine

bitemporal visual field defect

bromocriptine, slow release

carpal tunnel syndrome

CAT scan

CAT scan, abnormal

CAT scan, chest

catechol-o-methyltransferase inhibitor

cerebellar pontine angle

cerebellar pontine angle tumor

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chromophobe adenoma, treatment of

cirrhosis

cisternogram, radionuclide

congestive heart failure

conjunctival injection

constipation

controversies in neurology

coprolalia

coronary artery disease

cost effectiveness

cough

cranial nerve palsies

dexamethasone suppression test

diabetes mellitus

dialysis

diplopia

disability rating scale, neurological

disability, neurological

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

doppler, transcranial

downward gaze, paralysis of

driving

drug induced neurologic disorders

echocardiogram, transthoracic

edema, pedal

efficacy

emergencies, neurologic

eye movement, disorders of

fine motor function, impaired

follicle stimulating hormone

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

gene

gene mutation

Gilles de la Tourette syndrome

glabellar sign

goiter

growth hormone

growth hormone deficiency

guanfacine

hair, loss

hallucination

hallucination, auditory

haloperidol

handwriting

headache

headache, drug induced

headache, prophylaxis

headache, treatment of

hearing loss

hemidystonia

hepatic encephalopathy

hepatic encephalopathy, treatment of

heralding manifestation

hypothalamus, damage to

hypothermia

hypothyroidism

iatrogenic neurologic disorders

internuclear ophthalmoplegia

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

lergotrile

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

medication withdrawal

microsurgery, transsphenoidal

migraine

migraine, menses

migraine, prophylaxis

migraine, treatment of

misdiagnosis

mitral valve lesion

mitral valve regurgitation

monoamine oxidase inhibitors

mortality

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, treatment of

MRI

MRI, abnormal

MRI, contrast enhanced

narcolepsy

nausea and vomiting

Nelson's syndrome

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

nonsteroidal anti-inflammatory drug

obsessive-compulsive disorder

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

pathologic gambling

pathology

patient information and support

PHNO, enteral infusion, continuous

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

polyps, gastrointestinal tract

polysomnogram

postpartum

postpartum cerebral angiopathy

practice guidelines

pramipexole

pramipexole, extended release

pregabalin

pregnancy, neurologic complications in

prognosis

progressive supranuclear palsy

psychiatric problems in neurologic disorders

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

risk-benefit assessment

ropinirole

ropinirole, prolonged release

rotigotine

safety

seizure

sella turcica, enlargement of

sensorineural hearing loss

serotonin agonist

serum tumor markers

sinemet

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

sleep

sleep apnea

sleep pathology and physiology

smell

somatostatin analogue

stem cell transplantation

stimulation, deep brain

subclavian steal syndrome, causes of

testosterone, serum, low

thiothixene

tic

tic, classification of

transdermal medication

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

Unified Parkinson Rating Scale

visual acuity, decreased

Showing articles 150 to 200 of 648 << Previous Next >>

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984

Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984

Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984

Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984

Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984

Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984

Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984

Pergolide in Parkinson's Disease
Arch Neurol 40:785-787, Goetz,C.G.,et al, 1983

Hyperprolactinemia
Am J Med 75:868-874, Johnston,D.G.,et al, 1983

Urinary Incontinence in Patient on Long-Term Bromocriptine
Lancet 2:1260-1261, Sandyk,R.,et al, 1983

Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983

Failure of Bromocriptine to Maintain Reduction in Size of a Macroprolactinoma
BMJ 287:451-452, Breidahl,H.D.,et al, 1983

Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983

Bromocriptine & Lisuride in Parkinson Disease
Ann Neurol 13:44-47, Lieberman,A.N.,et al, 1983

Comparison of Pergolide & Bromocriptine Therapy in Parkinsonism
Neurol 33:1009-1014, LeWitt,P.A.,et al, 1983

Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983

Neuroleptic Malignant Syndrome, Successful Treatment with Bromocriptine
JAMA 249:386-388, Mueller,P.S.,et al, 1983

Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982

Size Reduction of Extrasellar Pituitary Tumors During Bromocriptine Treatment
Ann Int Med 96:281-286, Wollesen,F.,et al, 1982

Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982

Bromocriptine-induced psychosis in acromegaly
BMJ 285:1315, Lefeuvre,C.M.,et al, 1982

Bromocriptine:Low-dose Therapy in Parkinson Disease
Neurol 32:577-583, Teychenne,P.F.,et al, 1982

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Pergolide in Late-Stage Parkinson Disease
Ann Neurol 12:243-247, Lang,A.E.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982

CSF Rhinorrhea After Bromocriptine For Prolactinoma
NEJM 306:178, Baskin,D.S.,et al, 1982

Lisuride Versus Bromocriptine Treatment in Parkinson Disease:A Double-blind Study
Neurol 32:69-72, LeWitt,P.A.,et al, 1982

Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981

Bromocriptine Therapy for"Nonfunctioning"Pituitary Tumors
Am J Med 71:1059-1061, Johnston,D.G.,et al, 1981

Bromocriptine In Acromegaly
NEJM 305:1092-1093, Thorner,M.O.,et al, 1981

Effect Of Bromocriptine On Brain Metastasis In Breast Cancer
Lancet 2:745-746, Grisoli,F.,et al, 1981

Lisuride in Parkinson Disease:Efficacy of Lisuride Compared to Levodopa
Neurol 31:961-965, Lieberman,A.N.,et al, 1981

No Effect Of Bromocriptine In Acromegaly
NEJM 304:1450-1454, Lindholm,J.,et al, 1981

Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981

Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981

Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981

Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981

Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981

Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981

Alcohol Increases Bromocriptine's Side Effects
NEJM 302:806, Ayres,J.,et al, 1980

Increased Hair Loss As A Side Effect of Bromocriptine Treatment
NEJM 303:1418, Blum,I.,et al, 1980

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979

Bromocriptine Fails To Stop Growth of Eosinophilic Adenoma In Acromegaly
NEJM 301:386, Salti,I.S., 1979

Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979

The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979

Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979

The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979

Showing articles 150 to 200 of 648 << Previous Next >>